Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy Greggs (GRG) by Ben McPoland in The Motley Fool
- Sell Inspired (INSE) by Steve Moore in ShareProphets
- Neutral Schroders (SDR) by JP Morgan
- Sell Jaywing (JWNG) by Steve Moore in ShareProphets
- Sell Jubilee Metals Group (JLP) by Tom Winnifrith in ShareProphets
- Sell Jubilee Metals Group (JLP) by Steve Moore in ShareProphets
- Sell Tribe Technology (TRYB) by Steve Moore in ShareProphets
- Outperform Hollywood Bowl Group (BOWL) by RBC Capital
- Buy JD Sports Fashion (JD.) by Harvey Jones in The Motley Fool
- Hold Legal & General Group (LGEN) by Harvey Jones in The Motley Fool
- Sell Gelion (GELN) by Steve Moore in ShareProphets
- Buy GSK (GSK) by Harvey Jones in The Motley Fool
- Neutral Synthomer (SYNT) by UBS
- Neutral Carvana Co Class A (0A79) by UBS
- Equal Weight United Utilities Group (UU.) by Barclays
- Overweight Workspace Group (WKP) by Barclays
- Equal Weight Safestore Holdings (SAFE) by Barclays
- Equal Weight Severn Trent (SVT) by Barclays
- Overweight Pennon Group (PNN) by Barclays
- Overweight Land Securities Group (LAND) by Barclays
Sareum Holdings (SAR) Share Price
Health Care Sector
NOTE: This is based on 3 open tips for Sareum Holdings (SAR)
| Latest Bid : 26.00p | Latest Ask : 28.00p |
| High Today : 27.70p | Low Today : 26.52p |
| This Years High : 67.50p | This Years Low : 10.25p |
| Volume : 69,047 | MKT Cap : £33.75M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Sareum Holdings (SAR) Overview
Sareum discovers and develops innovative drug candidates aimed at cancers and autoimmune diseases. Our drug development programmes aim to improve outcomes for patients with serious medical conditions and where current therapies are inadequate.Sareum Holdings (SAR) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Peel Hunt | Premium Only | 2023-06-06 14:15:00 06/06/2023 | -80.71% |
| Long Term Buy | Royston Wild | Premium Only | 2021-08-22 07:55:00 22/08/2021 | -92.27% |
| Sell | Gary Newman | Premium Only | 2016-03-14 08:56:04 14/03/2016 | -15.25% |
Sareum Holdings (SAR) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 26.00p | Latest Ask : 28.00p |
| High Today : 27.70p | Low Today : 26.52p |
| This Years High : 67.50p | This Years Low : 10.25p |
| Volume : 69,047 | MKT Cap : £33.75M |
Sareum Holdings Overview
Sareum discovers and develops innovative drug candidates aimed at cancers and autoimmune diseases. Our drug development programmes aim to improve outcomes for patients with serious medical conditions and where current therapies are inadequate.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Sareum Holdings Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Peel Hunt | Premium Only | 2023-06-06 14:15:00 06/06/2023 | -80.71% |
| Long Term Buy | Royston Wild | Premium Only | 2021-08-22 07:55:00 22/08/2021 | -92.27% |
| Sell | Gary Newman | Premium Only | 2016-03-14 08:56:04 14/03/2016 | -15.25% |